Search This Blog

Tuesday, November 12, 2019

Editas Medicine EPS beats by $0.06, misses on revenue

Editas Medicine (NASDAQ:EDIT): Q3 GAAP EPS of -$0.66 beats by $0.06.
Revenue of $3.85M (-73.4% Y/Y) misses by $0.86M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)